These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10807191)

  • 1. Energy balance, viral burden, insulin-like growth factor-1, interleukin-6 and growth impairment in children infected with human immunodeficiency virus.
    Johann-Liang R; O'Neill L; Cervia J; Haller I; Giunta Y; Licholai T; Noel GJ
    AIDS; 2000 Apr; 14(6):683-90. PubMed ID: 10807191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth velocity, fat-free mass and energy intake are inversely related to viral load in HIV-infected children.
    Arpadi SM; Cuff PA; Kotler DP; Wang J; Bamji M; Lange M; Pierson RN; Matthews DE
    J Nutr; 2000 Oct; 130(10):2498-502. PubMed ID: 11015480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changed bone status in human immunodeficiency virus type 1 (HIV-1) perinatally infected children is related to low serum free IGF-I.
    Stagi S; Bindi G; Galluzzi F; Galli L; Salti R; de Martino M
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):692-9. PubMed ID: 15579182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resting energy expenditure and body composition in children with HIV infection.
    Henderson RA; Talusan K; Hutton N; Yolken RH; Caballero B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):150-7. PubMed ID: 9768624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 release by cultured peripheral blood mononuclear cells inversely correlates with height velocity, bone age, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 serum levels in children with perinatal HIV-1 infection.
    de Martino M; Galli L; Chiarelli F; Verrotti A; Rossi ME; Bindi G; Galluzzi F; Salti R; Vierucci A
    Clin Immunol; 2000 Mar; 94(3):212-8. PubMed ID: 10692240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of human recombinant growth hormone and human recombinant insulin-like growth factor-I in patients with human immunodeficiency virus infection.
    Hirschfeld S
    Horm Res; 1996; 46(4-5):215-21. PubMed ID: 8950624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered bone metabolism in children infected with human immunodeficiency virus.
    Zamboni G; Antoniazzi F; Bertoldo F; Lauriola S; Antozzi L; Tatò L
    Acta Paediatr; 2003; 92(1):12-6. PubMed ID: 12650292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy expenditure and wasting in human immunodeficiency virus infection.
    Macallan DC; Noble C; Baldwin C; Jebb SA; Prentice AM; Coward WA; Sawyer MB; McManus TJ; Griffin GE
    N Engl J Med; 1995 Jul; 333(2):83-8. PubMed ID: 7777033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth impairment, IGF I hyposecretion and thyroid dysfunction in children with perinatal HIV-1 infection.
    Matarazzo P; Palomba E; Lala R; Ciuti E; Altare F; de Sanctis L; Tovo PA
    Acta Paediatr; 1994 Oct; 83(10):1029-34. PubMed ID: 7841697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and plasma markers of nutritional status in children infected with the human immunodeficiency virus.
    Henderson RA; Talusan K; Hutton N; Yolken RH; Caballero B
    J Am Diet Assoc; 1997 Dec; 97(12):1377-81. PubMed ID: 9404333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous anabolic hormones and hypermetabolism: effect of trauma and gender differences.
    Jeschke MG; Barrow RE; Mlcak RP; Herndon DN
    Ann Surg; 2005 May; 241(5):759-67; discussion 767-8. PubMed ID: 15849511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole body protein turnover in children with human immunodeficiency virus (HIV) infection.
    Henderson RA; Talusan K; Hutton N; Yolken RH; Caballero B
    Nutrition; 1999 Mar; 15(3):189-94. PubMed ID: 10198912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro insulin-like growth factor-I, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected children.
    Geffner ME; Yeh DY; Landaw EM; Scott ML; Stiehm ER; Bryson YJ; Israele V
    Pediatr Res; 1993 Jul; 34(1):66-72. PubMed ID: 8356022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India.
    Banerjee T; Pensi T; Banerjee D; Grover G
    Ann Trop Paediatr; 2010; 30(1):27-37. PubMed ID: 20196931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.
    Rucker RP; Day NK; Good RA; Kamchaisatian W; Emmanuel P; Sleasman JW; Mayeski C; Dinglasan E; Haraguchi S; Tangsinmankong N
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):272-6. PubMed ID: 15478388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth failure in children with HIV infection.
    Arpadi SM
    J Acquir Immune Defic Syndr; 2000 Oct; 25 Suppl 1():S37-42. PubMed ID: 11126424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone improves protein catabolism and growth in prepubertal children with HIV infection.
    Hardin DS; Rice J; Doyle ME; Pavia A
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):259-62. PubMed ID: 16117811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profile of children with extrahepatic portal vein obstruction undergoing meso-Rex bypass.
    Lautz TB; Eaton S; Keys L; Ito J; Polo M; Wells JCK; Pierro A; Superina RA
    J Surg Res; 2018 Mar; 223():109-114. PubMed ID: 29433861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.